STOCK TITAN

IQST - IQSTEL Announces Strategic Digital Health Partnership and Investor Conference Call to Discuss Q4 & FY 2025 Results

(Moderate)
(Very Positive)
Tags
partnership conferences

IQSTEL (NASDAQ: IQST) announced a strategic Non-Binding Commercial MOU with a digital health technology company to enter the multi-billion-dollar Digital Health market and will discuss Q4 and FY2025 results on an investor call today.

The partnership aims to commercialize IoT medical devices, cloud platforms, RPM systems and AI analytics via IQSTEL's global telecom distribution reach to ~600 operators and ~2.3 billion end users, with a planned product introduction at International Telecoms Week (May 18–21, 2026).

Loading...
Loading translation...

Positive

  • MOU signed to enter Digital Health market
  • Global reach: access to ~600 telecom operators and ~2.3B end users
  • Planned commercial launch at ITW May 18–21, 2026
  • AI-driven platform combining IoT devices, RPM and cloud analytics

Negative

  • MOU is non-binding, so commercial terms remain unfinalized
  • Revenue opportunity unquantified; "multi-billion" claim lacks near-term commitments
  • No deal values or binding contracts disclosed to confirm material financial impact

News Market Reaction – IQST

-8.59%
8 alerts
-8.59% Session close to close
+5.9% Peak Tracked
-8.3% Trough Tracked
$9.13M Market Cap
1.3x Rel. Volume

In the Apr 7 session, IQST declined 8.59%, reflecting a notable negative market reaction. Argus tracked a peak move of +5.9% during that session. Argus tracked a trough of -8.3% from its starting point during tracking. Our momentum scanner triggered 8 alerts that day, indicating moderate trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

Market Context

The stock moved -8.6% in the session following this news. A negative reaction despite upbeat messagi...
Analysis

The stock moved -8.6% in the session following this news. A negative reaction despite upbeat messaging would fit the mixed pattern seen after prior strategic updates, where some positive news days still saw declines. The digital health MOU is non-binding and comes as the stock trades below its 200-day MA of $5.09 and far from the $18.69 52-week high, reflecting prior skepticism. Historical announcements tied to growth and AI have produced both rallies and pullbacks, so investors have not reacted uniformly.

Key Figures

Price change: 7.44% Current price: $1.805 52-week range: $1.48–$18.69 +5 more
8 metrics
Price change 7.44% Move prior to digital health partnership and earnings call
Current price $1.805 Before Q4/FY 2025 conference call
52-week range $1.48–$18.69 52-week low and high
Telecom reach 600+ operators Global telecom operators reached via IQSTEL platform
End-user access 2.3 billion users End users reached through partners via telecom platform
ITW 2026 dates May 18–21, 2026 Planned product launch window at International Telecoms Week
Earnings call time 8:30 AM ET Investor conference call on April 7, 2026
Conference dial-in 1-888-880-3330 / 1-646-357-8766 North America toll-free and international numbers

Historical Context

5 past events · Latest: Mar 31 (Positive)
Pattern 5 events
Date Event Sentiment 24h Move Catalyst
Mar 31 Earnings call preview Positive +1.3% Announced April 7 earnings call and outlined digital health expansion roadmap.
Mar 18 Shareholder letter Positive -1.6% Detailed AI platform development, cybersecurity partnership, and M&A evaluation.
Mar 09 Preliminary 2025 revenue Positive +8.0% Reported ~$317M 2025 revenue and higher EBITDA run rate targets.
Feb 26 AI platform launch Positive +3.1% Launched IQCortex AI orchestration platform aimed at margin expansion.
Feb 04 Annual meeting update Positive -3.2% Shared revenue run rate, EBITDA goals, and acquisition plans post shareholder meeting.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Positive strategic and growth updates often see constructive, but not uniformly positive, price reactions, with a mix of aligned and divergent moves.

Recent Company History

Over the past months, IQST released multiple growth-focused updates, including a $317M preliminary 2025 revenue figure and a $400M revenue run rate, plus AI platform launches and acquisition plans. These announcements often linked telecom scale across 600+ operators with higher-margin AI and fintech ambitions. Price reactions were mixed but skewed positive around major financial milestones. Today’s digital health partnership and earnings call details extend this strategy of layering new high-margin services onto the existing telecom platform.

Key Terms

memorandum of understanding, iot-based, remote patient monitoring, artificial intelligence
4 terms
memorandum of understanding regulatory
"announced the signing of a Non-Binding Commercial Memorandum of Understanding (MOU)"
A memorandum of understanding (MOU) is a formal agreement between two or more parties that outlines their shared intentions and plans to work together. It acts like a handshake in writing, clarifying each side’s roles and expectations before any official contract is signed. For investors, an MOU signals that parties are serious about collaboration, which can influence future business opportunities and potential growth.
iot-based technical
"The partner has developed an integrated ecosystem combining:IoT-based medical devices and wearables"
IoT-based describes products, services or systems that rely on the Internet of Things — networks of everyday devices equipped with sensors and connectivity that collect and share data. Investors care because IoT-based solutions can create ongoing revenue from device management and data services, improve operational efficiency like turning many simple tools into a coordinated system, and introduce risks such as security, data privacy and dependence on connectivity.
remote patient monitoring medical
"Cloud-based digital health platformsRemote patient monitoring (RPM) systems"
Remote patient monitoring is the ongoing collection and transmission of a person’s health data (such as heart rate, blood sugar, or blood pressure) from home or another non-clinical setting to healthcare providers using connected devices and secure networks. For investors, it matters because it can reduce hospital visits, create steady service and device revenue, and change how care is paid for—think of it as a home security system for health that can lower costs and improve outcomes.
artificial intelligence technical
"Artificial Intelligence (AI)-driven analytics and predictive healthcare insights"
Artificial intelligence is the ability of computers and machines to perform tasks that typically require human thinking, such as understanding language, recognizing patterns, or making decisions. For investors, it matters because AI can enhance efficiency, uncover new insights, and enable smarter strategies, potentially impacting the value and performance of companies that develop or utilize this technology.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

Company to Enter Multi-Billion Dollar Digital Health Market

NEW YORK, April 7, 2026 /PRNewswire/ -- IQSTEL Inc. (NASDAQ: IQST), a rapidly growing global telecommunications and technology company, today announced the signing of a Non-Binding Commercial Memorandum of Understanding (MOU) with a digital health technology company to establish a strategic partnership in the Digital Health sector, alongside hosting its investor conference call to discuss financial results for the fourth quarter and full year ended December 31, 2025.

Leandro Iglesias, President & CEO of IQSTEL, commented:

"This partnership represents a major milestone in our strategy to transform IQSTEL into a high-tech, high-margin platform company.

We have already built a strong global telecom business platform, and now we are leveraging that foundation to enter the Digital Health market—one of the fastest-growing sectors globally.

By combining our distribution capabilities with our Digital Health partner's proven technology, experience, and AI-driven solutions, we are creating a powerful opportunity to scale this business globally."

A Transformational Step into Digital Health

The newly signed MOU represents a significant milestone in IQSTEL's strategic evolution, marking its entry into the fast-growing Digital Health market, a multi-billion-dollar global opportunity.

Under the proposed partnership, IQSTEL is expected to leverage its global telecom platform to commercialize digital health services through telecom operators worldwide, positioning the Company as a key distribution channel in this emerging sector.

IQSTEL's Digital Health partner brings:

  • Over a decade of experience in digital health innovation

  • A strong track record in scalable healthcare solutions

  • Multiple international recognitions and industry awards

The partner has developed an integrated ecosystem combining:

  • IoT-based medical devices and wearables

  • Cloud-based digital health platforms

  • Remote patient monitoring (RPM) systems

  • Artificial Intelligence (AI)-driven analytics and predictive healthcare insights

Through AI capabilities, the platform enhances patient monitoring, enables early detection of health risks, and improves healthcare outcomes by transforming large volumes of medical data into actionable insights.

Leveraging IQSTEL's Global Telecom Platform for High-Margin Growth

IQSTEL has built a strong and scalable commercial platform, which already reaches over 600 of the largest telecom operators around the world, with access to approximately 2.3 billion end users through its partners.

This platform enables IQSTEL to:

  • Rapidly deploy new services globally

  • Introduce high-tech, high-margin recurring services

  • Scale without the need for additional infrastructure

The Digital Health market is experiencing strong structural growth driven by:

  • Aging populations

  • Rising healthcare costs

  • Increased adoption of remote monitoring and connected devices

IQSTEL believes this initiative represents a multi-billion-dollar annual revenue opportunity, with significant upside potential as adoption scales globally.

Product Launch Initiative

IQSTEL and its Digital Health partner are planning to officially introduce their joint digital health solutions during International Telecoms Week (ITW) 2026, which will be held in Washington, D.C. from May 18 to May 21, 2026.

This launch represents a key milestone in the commercialization strategy of the partnership, positioning IQSTEL to present its new Digital Health offerings directly to leading global telecom operators and industry stakeholders.

Prior to the event, the Company plans to disclose detailed information regarding the products and services that will be incorporated into IQSTEL's portfolio, providing further visibility into its Digital Health strategy and go-to-market approach.

Investor Conference Call – Today

IQSTEL is pleased to invite all shareholders and investors to participate in its Earnings Call, which will be held today:

Conference Call Details

April 7, 2026
8:30 AM ET

Management, including Leandro Iglesias (CEO) and Alvaro Cardona (CFO), will provide:

  • A detailed review of financial performance

  • Insights into the Company's business platform value

  • Strategic outlook for 2026

  • Additional details on the Digital Health initiative

A live Q&A session will follow, and a replay will be made available on webcast service.

About IQSTEL Inc.
IQSTEL Inc. (NASDAQ: IQST) is a global telecom and technology company operating in 21 countries with over 600 Telecommunication Carrier Interconnections. The company delivers international voice, SMS, messaging, connectivity, and mobile financial services to telecom operators and enterprise customers worldwide. Built through a decade of organic growth and strategic acquisitions, IQSTEL is now expanding into AI-powered communications and cybersecurity through its RealityBorder.com AI Division and Cycurion partnership.

For more information, please visit www.IQSTEL.com.

Official Investors Landing Page: www.landingpage.iqstel.com

Safe Harbor Statement:
Statements in this news release may be "forward-looking statements". Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions, or any other information relating to our future activities or other future events or conditions. Words such as "anticipate," "believe," "estimate," "expect," "intend", "could" and similar expressions, as they relate to the company or its management, identify forward-looking statements. These statements are based on current expectations, estimates, and projections about our business based partly on assumptions made by management. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following: our ability to successfully market our products and services; our continued ability to pay operating costs and ability to meet demand for our products and services; the amount and nature of competition from other telecom products and services; the effects of changes in the cybersecurity and telecom markets; our ability to successfully develop new products and services; our ability to complete complementary acquisitions and dispositions that benefit our company; our success establishing and maintaining collaborative, strategic alliance agreements with our industry partners; our ability to comply with applicable regulations; our ability to secure capital when needed; and the other risks and uncertainties described in our prior filings with the Securities and Exchange Commission.

These statements are not guarantees of future performance and involve risks, uncertainties, and assumptions that are difficult to predict. Therefore, actual outcomes and results may and are likely to differ materially from what is expressed or forecasted in forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date of this news release, and IQSTEL Inc. undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date of this news release.

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/iqst---iqstel-announces-strategic-digital-health-partnership-and-investor-conference-call-to-discuss-q4--fy-2025-results-302735456.html

SOURCE iQSTEL

FAQ

What did IQSTEL (IQST) announce about entering the Digital Health market on April 7, 2026?

IQSTEL announced a Non-Binding Commercial MOU to partner in Digital Health. According to the company, the collaboration combines its telecom distribution with a partner's IoT devices, cloud RPM and AI analytics to commercialize services globally.

How large is IQSTEL's distribution reach that supports the digital health initiative (IQST)?

IQSTEL reports access to ~600 telecom operators and ~2.3 billion end users. According to the company, that platform will be used to deploy recurring digital health services through operator partnerships worldwide.

When will IQSTEL (IQST) officially introduce its joint digital health solutions?

IQSTEL plans to present the joint digital health solutions at International Telecoms Week, May 18–21, 2026. According to the company, this launch targets global telecom operators and industry stakeholders for commercialization.

Does the IQSTEL digital health agreement create binding commitments for revenue or delivery?

No, the announcement is a non-binding MOU and does not create final contractual revenue commitments. According to the company, detailed commercial terms and product disclosures will be provided before ITW 2026.

What technologies will IQSTEL (IQST) and its partner use in the digital health offering?

The joint offering will include IoT medical devices, cloud platforms, RPM systems, and AI-driven analytics. According to the company, AI capabilities will enable predictive insights and improved remote patient monitoring.